ScholarIQanswers from OpenAlex

Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer

PaperCitations, authors & open-access status

Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer have?

ScholarIQcitation count

Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer has 72 citations in the OpenAlex counts ScholarIQ stores.

When was Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer published?

ScholarIQyear

Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer has 2023 year in the ScholarIQ index.

What is the open-access status of Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer?

ScholarIQoa status

Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer has gold oa status in the ScholarIQ index.

What is the DOI of Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer?

ScholarIQdoi

The DOI for Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer is on the source record.

What is the PMID of Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer?

ScholarIQpmid

The PMID for Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer is on the source record.

What is the OpenAlex record for Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer?

ScholarIQopenalex

The OpenAlex for Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial